Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20111
20131
20153
20161
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern2
Bayer1
Boston Scientific Corporation1
Maastricht University Medical Center1
Newcastle University1
Quantgene Inc.1
Swiss Cancer Institute1
Terumo Europe N.V.1
University Hospital, Geneva1
University of Lausanne Hospitals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular11
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Liver Neoplasms2
Melanoma2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Adrenal Cortex Neoplasms1
Anorexia1
Bile Duct Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.